Friday 28 July marks the World Health Organization's (WHO) World Hepatitis Day — an opportunity "to add momentum to all efforts to all efforts to implement the WHO's global health sector strategy on hepatitis for 2016–2021 and help countries achieve the final goal — to eliminate hepatitis." Read The Pharmaceutical Journal's special report on tackling this group of diseases.
An intervention designed to help GP practices identify and refer patients for hepatitis C testing and treatment is both effective and cost-effective, research published in the BMJ has found.
Substance misuse and needle exchange patients in Newcastle will be given “up to £25 of Greggs vouchers” if they present for a blood spot test for hepatitis C in a community pharmacy.
Testing individuals with any risk factor for the hepatitis C virus is more cost effective than restricting screening to people with a history of injecting drugs, a study based in the Isle of Wight has found.
New clinical roles in cardiovascular disease and hepatitis C in community pharmacy contractSubscription
Community pharmacists could be involved in detecting undiagnosed cardiovascular disease under plans laid out in the ‘The Community Pharmacy Contract Framework for 2019/20 to 2023/24’.
Deaths from liver disease related to serious hepatitis C fell by more than 16% between 2015 and 2017, according to data published by Public Health England.
New hepatitis C infections have dropped almost 70% in HIV+ men in London since 2015, study showsSubscription
Incidence of hepatitis C has fallen by almost 70% in HIV positive men who have sex with men living in London since 2015, according to research presented at a major HIV conference.
Study shows needle and syringe programmes reduce transmission of hepatitis C while delivering cost savings.